Alpert M A, Bauer J H, Parker B M, Brooks C S, Freeman J A
Chest. 1979 Oct;76(4):379-83. doi: 10.1378/chest.76.4.379.
To assess the effect of minoxidil on pulmonary hemodynamics, we performed cardiac catheterization on ten patients, prior to the administration of minoxidil, at six months after its addition to their existing drug regimens, and on seven patients following 12 or more months of minoxidil therapy. Systemic blood pressure and systemic vascular resistance were significantly reduced at six months and following 12 or more months of minoxidil therapy. Before receiving minoxidil, nine of ten patients had elevated pulmonary vascular resistance. There were no significant changes in pulmonary vascular resistance following the initiation of minoxidil. The data suggest that pulmonary hypertension is common in patients with long-standing poorly controlled systemic hypertension, and that minoxidil, in doses sufficient to significantly reduce systemic blood pressure, does not cause or aggravate pulmonary hypertension.
为评估米诺地尔对肺血流动力学的影响,我们对10例患者进行了心导管检查,分别在给予米诺地尔之前、在其加入现有药物治疗方案6个月后以及7例接受米诺地尔治疗12个月或更长时间后进行。在米诺地尔治疗6个月及12个月或更长时间后,体循环血压和体循环血管阻力显著降低。在接受米诺地尔治疗前,10例患者中有9例肺血管阻力升高。开始使用米诺地尔后,肺血管阻力没有显著变化。数据表明,肺动脉高压在长期系统性高血压控制不佳的患者中很常见,并且剂量足以显著降低体循环血压的米诺地尔不会引起或加重肺动脉高压。